Transgene Biotek Ltd share price logo

Transgene Biotek Ltd Share Price (526139)

Check the latest share price of Transgene Biotek Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹4.250.24%

as on 04:01PM, 13 Jun 2025

BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Transgene Biotek Ltd Stock Performance

Get live Transgene Biotek Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹4.17
    Day's Price Range
    ₹4.3
  • 52 Week's Low

    52 Week's High

    ₹3.22
    52-Week Price Range
    ₹10.84
1 Month Return+ 10.97 %
3 Month Return+ 10.68 %
1 Year Return-52.67 %
3 Year Return+ 20.06 %
5 Year Return-11.09 %
Previous Close₹4.24
Open₹4.30
Volume5,563.00
Upper Circuit₹4.32
Lower Circuit₹4.16

Transgene Biotek Ltd Fundamentals & Key Indicators

Check Transgene Biotek Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹32.20 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

-53.13

Return on capital employed (ROCE)

0

Industry PE ratio

102.48

Beta (LTM)

0.17

P/B Ratio

-8.95

Dividend Yield

0

PEG Ratio

-2656.25

Quarterly Earnings Growth YOY

162.96

EPS (TTM)

-0.09

Sector

Healthcare

Book Value

1.41

Technical Analysis

How to invest in Transgene Biotek Ltd?

Investing in Transgene Biotek Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Transgene Biotek Ltd or 526139 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Transgene Biotek Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Transgene Biotek Ltd with just a few clicks!

Transgene Biotek Ltd Stock's Interest Amongst Investors

73%

Period Jun 15, 2025 to May 16, 2025. Change in 30 Days vs previous period

Search interest for Transgene Biotek Ltd Stock has increased by 73% in the last 30 days, reflecting an upward trend in search activity.

Transgene Biotek Ltd Valuation

Track how Transgene Biotek Ltd P/E has moved over time to understand its valuation trends.

Transgene Biotek Ltd in the last 5 years

  • Overview

  • Trends

Lowest (-227.67x)

December 31, 2024

Today (-53.13x)

June 13, 2025

Industry (102.48x)

June 13, 2025

Highest (13.23x)

October 8, 2018

LowHigh

Today’s Price to Earnings Ratio: -53.13x

Transgene Biotek Ltd Financial Results

Get the annual and quarterly financial summary of Transgene Biotek Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

0 (0%)0 (0%)0 (20%)0 (33%)0 (0%)
Net Income

(in ₹ Cr)

-0 (0%)0 (174%)-0 (135%)-0 (29%)-1 (689%)
Net Profit Margin-540.00% (0%)400.00% (174%)-116.67% (129%)-112.50% (4%)-887.50% (689%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

47 (0%)37 (21%)32 (13%)32 (0%)
Total Liabilities

(in ₹ Cr)

42 (0%)37 (12%)39 (3%)39 (2%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

0 (0%)0 (93%)0 (900%)0 (100%)0 (0%)

Transgene Biotek Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Transgene Biotek Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
21.68%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
70.04%
0.00
Others
8.28%
0.00

Transgene Biotek Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Transgene Biotek Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA32.20-2.22%1.11-1NA
NA231.08-2.83%0.59222
NA29.86-15.8%0.67-313
NA28.60121.89%0.62322
NA47.55-9.77%0.51159

Insights on Transgene Biotek Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 0.1 Cr → 0.12 Cr (in ₹), with an average increase of 8.3% per quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 21.68% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 70.04% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Vimta Labs Ltd has given 223.6% return, outperforming this stock by 203.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Vimta Labs Ltd has given 104.5% return, outperforming this stock by 157.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 0.2 Cr → -0.71 Cr (in ₹), with an average decrease of 284.2% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, Transgene Biotek stock has moved down by -41.8%

About Transgene Biotek Ltd

Transgene Biotek is a public limited company incorporated in Mar.90, engaged in research and development and manufacturing of medical reagents for diagnosis of diseases. It exports nutrients to African countries, Russia, China, Malaysia and the Philippines. The company is implementing a new project at Bollaram Anrich Industrial Area costing Rs.30 crore to set up a new manufacturing facility. The plant will work on four types of products – oral delivery of proteins and peptides, DNA vaccines, fusion proteins and biotherapeutics. The project will be funded by way of preferential offer to Batterymarch Financial Management in USA and other financial institutions.

Revenue: ₹0.08Cr as on March 2025 (Q4 FY25)
Net Profit: ₹0.71Cr as on March 2025 (Q4 FY25)
Chairperson Name: K Koteswara Rao
OrganisationTransgene Biotek Ltd
IndustryHealthcare
CEOK Koteswara Rao
E-voting on sharesClick here to vote

FAQs

What is Transgene Biotek Ltd share price today?

Transgene Biotek Ltd share price today stands at ₹4.25, Open: ₹4.3, Previous Close: ₹4.24, High: ₹4.3, Low: ₹4.17, 52 Week High: ₹10.84, 52 Week Low: ₹3.22.

What is today's traded volume of Transgene Biotek Ltd?

Today's traded volume of Transgene Biotek Ltd is 5,563.00. Which means that 5,563.00 shares of Transgene Biotek Ltd were bought and sold on the stock market during today's trading session.

What is Transgene Biotek Ltd's market cap today?

Today's market capitalisation of Transgene Biotek Ltd is ₹32.20 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Transgene Biotek Ltd?

Transgene Biotek Ltd’s 52 week high is ₹10.84 and 52 week low is ₹3.22. The current share price of Transgene Biotek Ltd is ₹4.25, which is -60.79% down from its 52 week high and 31.99% up from its 52 week low.